Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
Open Access
- 5 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2), e55565
- https://doi.org/10.1371/journal.pone.0055565
Abstract
White matter lesions (WML) are clinically relevant since they are associated with strokes, cognitive decline, depression, or epilepsy, but the underlying etiology in young adults without classical risk factors still remains elusive. Our aim was to elucidate the possible clinical diagnosis and mechanisms leading to WML in patients carrying the D313Y mutation in the α-galactosidase A (GLA) gene, a mutation that was formerly described as nonpathogenic. Pathogenic GLA mutations cause Fabry disease, a vascular endothelial glycosphingolipid storage disease typically presenting with a symptom complex of renal, cardiac, and cerebrovascular manifestations. We performed in-depths clinical, biochemical and genetic examinations as well as advanced magnetic resonance imaging analyses in a pedigree with the genetically determined GLA mutation D313Y. We detected exclusive neurologic manifestations of the central nervous system of the “pseudo”-deficient D313Y mutation leading to manifest WML in 7 affected adult family members. Furthermore, two family members that do not carry the mutation showed no WML. The D313Y mutation resulted in a normal GLA enzyme activity in leukocytes and severely decreased activities in plasma. In conclusion, our results provide evidence that GLA D313Y is potentially involved in neural damage with significant WML, demonstrating the necessity of evaluating patients carrying D313Y more thoroughly. D313Y might broaden the spectrum of hereditary small artery diseases of the brain, which preferably occur in young adults without classical risk factors. In view of the existing causal therapy regime, D313Y should be more specifically taken into account in these patients.This publication has 31 references indexed in Scilit:
- Apports du génotypage dans la maladie de FabryLa Revue de Médecine Interne, 2010
- Frequency of Fabry disease in male and female haemodialysis patients in SpainBMC Medical Genetics, 2010
- Frequency of Unrecognized Fabry Disease Among Young European-American and African-American Men With First Ischemic StrokeStroke, 2010
- Treat the patient not the lab valueClinical Kidney Journal, 2009
- Invited Article: An MRI-based approach to the diagnosis of white matter disordersNeurology, 2009
- White matter hyperintensities in mid-adult lifeCurrent Opinion in Psychiatry, 2008
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*American Journal of Human Genetics, 2006
- Age, Hypertension, and Lacunar Stroke Are the Major Determinants of the Severity of Age-Related White Matter ChangesCerebrovascular Diseases, 2006
- Fabry disease: correlation between structural changes in α-galactosidase, and clinical and biochemical phenotypesHuman Genetics, 2005
- Fabry disease: Characterization of ?-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency alleleHuman Mutation, 2003